Key result
Blocking CCR5 with maraviroc reduces acute lung injury and inhibits autophagy in a DHCA rat model.
Why the study?
The mechanisms by which CCR5+ inflammatory monocytes contribute to acute lung injury following deep hypothermic circulatory arrest were unclear.
Does allosteric CCR5 drug blockade alleviate lung injury in a rat model of DHCA-induced acute lung injury?
Does allosteric CCR5 drug blockade alleviate lung injury in a rat model of DHCA-induced acute lung injury?
p-value: p=<0.05
Blocking CCR5 may be a plausible intervention for DHCA-induced acute lung injury by modulating autophagy and reducing inflammatory monocyte recruitment.
CCR5+ monocyte recruitment may drive rat DHCA-ALI and respond to blockade; leaves open any clinical translation.
Acute lung injury (ALI) is a common serious complication following deep hypothermic circulatory arrest (DHCA). Monocytes and macrophages play crucial roles in producing inflammatory mediators and regulating innate and adaptive immunity. In our specific rat model of DHCA-induced ALI, we previously showed that autophagy actually has a detrimental effect on lung injury rather than a protective effect. Recently, we reported that monocytes serve an important role in this model. Here, single-cell RNA sequencing was performed on lung tissue cells collected from healthy rats and rats after DHCA. Notably, there was a selective and dramatic increase in the subpopulation of CD43 low monocytes in the DHCA group, which expressed high levels of CCR5 and exhibited a proinflammatory phenotype. Allosteric CCR5 drug blockade not only reduced CCR5 expression and alleviated lung injury but also, interestingly, inhibited autophagy. These results suggest that the recruitment of CCR5 + inflammatory monocytes into pulmonary tissue contributes to ALI after DHCA and that blocking CCR5 is a plausible intervention for DHCA-induced lung injury by modulating autophagy.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2025) studied Acute lung injury following deep hypothermic circulatory arrest. Maraviroc (CCR5 inhibitor) or Clodronate-liposomes vs. Sham or DHCA with vehicle/PBS was evaluated on Lung injury severity, monocyte recruitment, and autophagy levels (p=<0.05). In a rat model of deep hypothermic circulatory arrest, blocking CCR5 with maraviroc or depleting monocytes significantly reduced acute lung injury and inhibited autophagy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: